These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1382421)

  • 1. The non specificity of specific nitric oxide synthase inhibitors.
    Peterson DA; Peterson DC; Archer S; Weir EK
    Biochem Biophys Res Commun; 1992 Sep; 187(2):797-801. PubMed ID: 1382421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA.
    Babbedge RC; Hart SL; Moore PK
    J Pharm Pharmacol; 1993 Jan; 45(1):77-9. PubMed ID: 7679442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors.
    Laszlo F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
    Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
    Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
    Bogle RG; Moncada S; Pearson JD; Mann GE
    Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro.
    Belenky SN; Robbins RA; Rubinstein I
    J Leukoc Biol; 1993 May; 53(5):498-503. PubMed ID: 7684763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of NG-substituted arginines on coronary vascular function after endotoxin.
    Winn MJ; Vallet B; Asante NK; Curtis SE; Cain SM
    J Appl Physiol (1985); 1993 Jul; 75(1):424-31. PubMed ID: 7690746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats.
    Gardiner SM; Kemp PA; Bennett T; Palmer RM; Moncada S
    Eur J Pharmacol; 1992 Mar; 213(3):449-51. PubMed ID: 1377633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats.
    Plourde V; Quintero E; Suto G; Coimbra C; Taché Y
    Eur J Pharmacol; 1994 Apr; 256(2):125-9. PubMed ID: 7519557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
    Adeagbo AS; Triggle CR
    Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central inhibition of nitric oxide synthase preferentially augments release of oxytocin during dehydration.
    Summy-Long JY; Bui V; Mantz S; Koehler E; Weisz J; Kadekaro M
    Neurosci Lett; 1993 Apr; 152(1-2):190-3. PubMed ID: 7685865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Petros A; Bennett D; Vallance P
    Lancet; 1991 Dec 21-28; 338(8782-8783):1557-8. PubMed ID: 1720856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.
    Shimizu S; Nomoto M; Yamamoto T; Momose K
    Br J Pharmacol; 1994 Oct; 113(2):564-8. PubMed ID: 7530574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.
    Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK
    Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nitric oxide synthase inhibitors on gastric alkaline secretion in rats.
    Takeuchi K; Ohuchi T; Miyake H; Sugawara H; Okabe S
    Jpn J Pharmacol; 1992 Nov; 60(3):303-5. PubMed ID: 1283424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
    MacAllister RJ; Fickling SA; Whitley GS; Vallance P
    Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of nitric oxide synthetase prevent castor-oil-induced diarrhoea in the rat.
    Mascolo N; Izzo AA; Barbato F; Capasso F
    Br J Pharmacol; 1993 Apr; 108(4):861-4. PubMed ID: 7683565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of nitric oxide synthase enhance rat ileum contractions induced by ricinoleic acid in vitro.
    Izzo AA; Mascolo N; Viola P; Capasso F
    Eur J Pharmacol; 1993 Oct; 243(1):87-90. PubMed ID: 7504631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages.
    Baydoun AR; Mann GE
    Biochem Biophys Res Commun; 1994 Apr; 200(2):726-31. PubMed ID: 7513994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.